Immunochemical studies of antigenic lymphoma-associated proteins

British Journal of Haematology

Volumn 116, Issue 1, 2002, Pages 135-141

  Pulford, Karen ^a   Roberton, Helen ^a   Banham, Alison H ^a   Hatton, Christian S R ^b   Mason, David Y ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Autoantibodies; Immunoprecipitation; Tumour associated antigens; Western blotting

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; AUTOANTIBODY; NUCLEOPHOSMIN; PROTEIN ANTIBODY; PROTEIN BCL 2; TUMOR ANTIGEN;

ANIMAL CELL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGEN PURIFICATION; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; ISOTOPE LABELING; LEUKEMIA CELL LINE; LYMPHOMA CELL LINE; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TONSIL;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; AUTOANTIBODIES; AUTORADIOGRAPHY; BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; JURKAT CELLS; LYMPHOMA, FOLLICULAR; PRECIPITIN TESTS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; SULFUR RADIOISOTOPES;

EID: 0036164842     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03252.x     Document Type: Article

References (47)

1. The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000
2. Immune responses to all ErbB family receptors detectable in serum of cancer patients
3. ALK-positive lymphoma. A single disease with a broad spectrum of morphology
4. Cancer tumor antigens
5. Role of amplified genes in the production of autoanti-bodies
6. Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B cell lymphoma
7. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: A novel strategy for identifying metaplastic lesions
8. Gene expression profiling: Monitoring transcription and translation products using DNA microarrays and proteomics
9. p53 autoantibodies in patients with malignant mesothelioma: Stability through disease progression
10. Oncogenic proteins as tumour antigens
11. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas
12. Expression of the bcl-2 gene product in follicular lymphoma
13. HUB1 is an autoantigen frequently eliciting humoral immune response in patients with adult T cell leukemia
14. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: Definition of human histocompatibility leucocyte antigen (HLA)-A2-binding peptide epitopes
15. Peptide vaccination in clinical oncology
16. Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses
17. Epstein-Barr virus and other candidate viruses in the pathogenesis of Hodgkin's disease
18. The circulating auto-antibodies to p53 in the follow-up of lymphoma patients
19. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognise EBV-immortalised B cells transfected with polymorphic epithelial mucin complementary DNA
20. Proteomics in human disease. Cancer, heart and infectious diseases
21. Antibodies against p40tax gene product of human T-lymphotropic virus type-1 (HTLV-1) under various conditions of HTLV-1 infection
22. BCL-2 gene family and the regulation of programmed cell death
23. Autoantibodies to c-myc protein: Elevated levels in patients with African Burkitt's lymphoma and normal Ghanians
24. Bcl-2 expression in adult and embryonic non-haematopoietic tissues
25. Double immunocytochemical labeling of cell and tissue samples with monoclonal anti-bromodeoxyuridine
26. Survival in early breast cancer patients is favourably influenced by a natural humoral immune response to polymorphic epithelial mucin
27. Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer
28. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
29. Overexpression of the BCL-2 protein increases the half-life of p21Bax
30. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma
31. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) translocation
32. Proteomics to study genes and genomes
33. Expression of the bcl-2 oncogenic protein is not specific for the 14; 18 chromosomal translocation
34. Detection of ana-plastic lymphoma linase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1
35. Lymphocyte-specific protein 1: A specific marker of human leucocytes
36. Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of ana-plastic large cell lymphoma
37. Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma
38. Human neoplasms elicit multiple specific immune responses in the autologous host
39. Mass spectrometric sequencing of proteins from silver-stained poly-acrylamide gels
40. Hyperphosphorylation of a novel 80 kDa protein tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3
41. CD30 (+) anaplastic large cell lymphoma. A review of its histopathologic, genetic, and clinical features
42. Detection of p73 antibodies in patients with various types of cancer: Immunological characterisation
43. Bcl-2 inhibits T-cell mediated cytolysis of a leukaemia cell line
44. Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma
45. Molecular definition of a novel human gelectin which is immunogenic in patients with Hodgkin's disease
46. Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens
47. The significance of p53 autoantibodies in the serum of patients with breast cancer